Nearly a year after Montana began receiving millions of dollars to invest in efforts to combat the opioid crisis, much of that money remains untouched. Meanwhile, the state’s opioid overdose and death counts continue to rise.
Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund
Plus, news about Phathom and CANbridge: Avidity Biosciences closes $345.1M offering: The raise comes on the heels of Phase 1/2 data … Sign up to
August 20, 2024